Most dogs with bladder cancer live roughly 4 to 10 months after diagnosis, depending on the treatment approach. With the most effective combination therapies, some dogs survive well past two years. The most common type of bladder cancer in dogs is transitional cell carcinoma (TCC), an aggressive tumor that grows in the bladder lining and often spreads to other parts of the body over time.
Survival Times by Treatment
The treatment your dog receives has the single biggest impact on how long they live after a bladder cancer diagnosis. Here’s what the data shows for median survival times, meaning half of dogs lived longer and half lived shorter:
- Anti-inflammatory medication alone (piroxicam or similar): 127 days (range: 42 to 635 days)
- Surgery combined with anti-inflammatory medication: 194 days (range: 1 to 562 days)
- Standard chemotherapy: 219 days (range: 74 to 484 days)
- Low-dose ongoing chemotherapy: 303 days (range: 36 to 862 days)
Those ranges are important. A dog on anti-inflammatory medication alone might live just six weeks or might live nearly two years. A dog receiving low-dose ongoing chemotherapy could survive close to two and a half years. Individual outcomes vary enormously based on tumor size, location, and how early the cancer is caught.
What Affects Your Dog’s Prognosis
Three factors consistently shorten survival time, based on research from Purdue University’s oncology program: a larger tumor within the bladder, cancer that has spread beyond the bladder wall, and tumor involvement in the prostate gland (in male dogs).
About 20% of dogs already have detectable spread of cancer at the time of diagnosis. By the time dogs die from TCC, 50 to 60% have metastasis, most commonly to lymph nodes and lungs. This means the cancer is often more advanced than it first appears, and staging (imaging and testing to determine how far the cancer has spread) plays a critical role in shaping a realistic prognosis.
Why Surgery Isn’t Always an Option
Bladder cancer in dogs tends to grow in a location that makes complete surgical removal difficult or impossible. The tumor often develops at the trigone, the area where the ureters connect to the bladder and urine exits through the urethra. Removing this area would mean removing the plumbing that allows your dog to urinate normally.
When the tumor is in a favorable location, partial removal of the bladder wall combined with anti-inflammatory medication gives a median survival of about 194 days. Surgery isn’t a cure, but it can reduce the tumor burden and improve comfort while other treatments work to slow regrowth.
How Treatment Works Day to Day
The most common first-line treatment is an anti-inflammatory drug called piroxicam, given as a daily or every-other-day pill at home. This type of medication does more than reduce inflammation. It has direct anti-tumor effects on bladder cancer cells and can slow tumor growth on its own. For many dogs, this is well tolerated with minimal side effects.
Chemotherapy for bladder cancer in dogs is generally less intense than what people picture from human cancer treatment. Low-dose ongoing protocols, which produced the longest median survival in the research (303 days), use smaller, more frequent doses of medication rather than high-dose cycles. Many dogs tolerate this well and maintain a good quality of life throughout treatment. Standard chemotherapy, given in larger doses at intervals, produced a median survival of 219 days.
Your veterinary oncologist will typically combine approaches. Anti-inflammatory medication is often used as a foundation alongside chemotherapy or after surgery, since each treatment attacks the cancer through a different mechanism.
When the Tumor Blocks Urination
One of the most urgent complications of bladder cancer is urinary obstruction. As the tumor grows, it can physically block the urethra and prevent your dog from urinating. This is a medical emergency.
When obstruction occurs, a urethral stent (a small tube placed inside the urethra to hold it open) can restore the ability to urinate. In one documented case, a dog regained normal urination for just over 200 days after stent placement. Stents don’t treat the cancer itself, but they can buy meaningful time and relieve significant discomfort. Standard cancer treatments like surgery and chemotherapy are not effective for immediate relief of a complete blockage.
Catching It Earlier
A urine-based test that detects a specific genetic mutation (called the BRAF mutation) can identify bladder cancer with 85% sensitivity and over 99% specificity. That means if the test comes back positive, it’s almost certainly correct. It also means about 15% of cancer cases will be missed by a negative result.
The test can pick up tiny numbers of cancer cells, making it useful as a screening tool for breeds at higher risk, including Scottish Terriers, Shetland Sheepdogs, Beagles, West Highland White Terriers, and Wire Fox Terriers. For at-risk breeds over six years old showing even mild urinary symptoms like frequent urination, straining, or blood in the urine, this test can catch the disease before it becomes advanced. Earlier detection generally means more treatment options and a better chance of landing on the longer end of those survival ranges.
Signs the Disease Is Progressing
Bladder cancer in dogs typically starts with symptoms that look a lot like a urinary tract infection: frequent urination, straining, and blood-tinged urine. In fact, many dogs are initially treated for a UTI before the cancer is discovered. As the disease progresses, you may notice your dog straining more, producing only small amounts of urine, having accidents in the house, or losing interest in food and activity.
The shift from manageable disease to declining quality of life often centers on urinary function. When the tumor grows large enough to cause persistent pain, repeated obstruction, or kidney damage from urine backing up, the dog’s comfort deteriorates significantly. Weight loss, lethargy, and loss of appetite in the later stages typically signal that the cancer has spread or that the bladder is no longer functioning well enough to maintain comfort.